321318-11-0 Usage
Uses
Used in Pharmaceutical Industry:
1-(3,5-difluorophenyl)ethan-1-amine hydrochloride is used as a pharmaceutical intermediate for the synthesis of various medications and drug products. Its role in this industry is crucial, as it aids in the creation of a wide range of therapeutic agents.
Used in Drug Development:
1-(3,5-difluorophenyl)ethan-1-amine hydrochloride is used as a potential candidate in the development of new drugs due to its possible pharmacological properties. Its unique structure and reactivity make it a valuable asset in the design and synthesis of innovative therapeutic agents.
Used in Chemical and Biological Research:
1-(3,5-difluorophenyl)ethan-1-amine hydrochloride is also utilized as a research tool or reagent in chemical and biological studies. Its application in this field allows scientists to explore its properties and potential interactions with other molecules, furthering the understanding of its capabilities and uses in various scientific disciplines.
Check Digit Verification of cas no
The CAS Registry Mumber 321318-11-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,2,1,3,1 and 8 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 321318-11:
(8*3)+(7*2)+(6*1)+(5*3)+(4*1)+(3*8)+(2*1)+(1*1)=90
90 % 10 = 0
So 321318-11-0 is a valid CAS Registry Number.
321318-11-0Relevant articles and documents
BISAMIDE SARCOMERE ACTIVATING COMPOUNDS AND USES THEREOF
-
Paragraph 0222-0223, (2019/03/30)
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising a compound of the invention, a method for manufacturing compounds of the invention and therapeutic uses thereof.
ISOQUINOLINE COMPOUNDS, A PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
-
, (2017/06/12)
A compound of formula (I): wherein the substituents are as defined in the description. Medicinal products containing the same which are useful in treating or preventing pathologies which are the result of activation of the RhoA/ROCK pathway and phosphorylation of the myosin light chain.
PYRIMIDINEDIONE COMPOUNDS AGAINST CARDIAC CONDITIONS
-
, (2015/01/07)
Provided are novel pyrimidine dione compounds and pharmaceutically acceptable salts thereof, that are useful for the treatment of hypertrophic cardiomyopathy (HCM) and conditions associated with left ventricular hypertrophy or diastolic dysfunction. The synthesis and characterization of the compounds and pharmaceutically acceptable salts thereof, are described, as well as methods for treating HCM and other forms of heart disease.
